Role of CD25 expression on prognosis of acute myeloid leukemia: A literature review and meta-analysis | PLOS ONE
Cancers | Free Full-Text | Real-World Experience of Measurable Residual Disease Response and Prognosis in Acute Myeloid Leukemia Treated with Venetoclax and Azacitidine
Overalls | TERWIJN ZWOLLE BEDRIJFSKLEDING
Overalls | TERWIJN ZWOLLE BEDRIJFSKLEDING
Measurable residual disease (MRD) status before allogeneic hematopoietic cell transplantation impact on secondary acute myeloid leukemia outcome. A Study from the Acute Leukemia Working Party (ALWP) of the European society for Blood
Overalls | TERWIJN ZWOLLE BEDRIJFSKLEDING
Overalls | TERWIJN ZWOLLE BEDRIJFSKLEDING
A new class of leaders | Article | The United States Army
The Evolving Treatment Landscape of AML | Published in healthbook TIMES Oncology Hematology
Acute myeloid leukemia: 2019 update on risk‐stratification and management - Estey - 2018 - American Journal of Hematology - Wiley Online Library
Overalls | TERWIJN ZWOLLE BEDRIJFSKLEDING
Ibrutinib added to 10-day decitabine for older patients with AML and higher risk MDS - ScienceDirect
Prognostic impact of complete remission with MRD negativity in patients with relapsed or refractory AML - ScienceDirect
Frontiers | Concordance in measurable residual disease result after first and second induction cycle in acute myeloid leukemia: An outcome- and cost-analysis
Overalls | TERWIJN ZWOLLE BEDRIJFSKLEDING
Overalls | TERWIJN ZWOLLE BEDRIJFSKLEDING
Unified classification and risk-stratification in Acute Myeloid Leukemia | Nature Communications
▷ Terwijn Zwolle Overalls en Spijkerbroeken
Leukemic Stem Cell Frequency: A Strong Biomarker for Clinical Outcome in Acute Myeloid Leukemia – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka
PDF) The Weekend School Effect on Perceived Cognitive and Social Competences: Evidence from a Randomized Controlled Experiment
A new class of leaders | Article | The United States Army
TERWIJN ZWOLLE BEDRIJFSKLEDING | Werkkleding en meer
Second cycle remission achievement with 7+3 and survival in adults with newly diagnosed acute myeloid leukemia: analysis of recent SWOG trials | Leukemia
